Biomerica (BMRA) Revenue & Revenue Breakdown
Biomerica Revenue Highlights
Latest Revenue (Q)
$1.02M
Main Segment (Y)
ClinicalLabMember
Main Geography (Y)
ClinicalLabMember
Biomerica Revenue by Period
Biomerica Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-05-31 | - | -100.00% |
| 2023-05-31 | $5.34M | -71.71% |
| 2022-05-31 | $18.87M | 162.14% |
| 2021-05-31 | $7.20M | 7.57% |
| 2020-05-31 | $6.69M | 28.69% |
| 2019-05-31 | $5.20M | -6.53% |
| 2018-05-31 | $5.56M | -3.93% |
| 2017-05-31 | $5.79M | 12.68% |
| 2016-05-31 | $5.14M | 3.58% |
| 2015-05-31 | $4.96M | -3.09% |
| 2014-05-31 | $5.12M | -20.89% |
| 2013-05-31 | $6.47M | 6.44% |
| 2012-05-31 | $6.08M | 24.12% |
| 2011-07-29 | $4.90M | -3.46% |
| 2010-05-31 | $5.08M | 2.85% |
| 2009-05-31 | $4.93M | 0.17% |
| 2008-05-31 | $4.93M | -14.30% |
| 2007-05-31 | $5.75M | -20.00% |
| 2006-05-31 | $7.18M | -22.53% |
| 2005-05-31 | $9.27M | 1.15% |
| 2004-05-31 | $9.17M | 1.20% |
| 2003-05-31 | $9.06M | 5.37% |
| 2002-05-31 | $8.60M | -3.82% |
| 2001-05-31 | $8.94M | 11.28% |
| 2000-05-31 | $8.03M | -7.66% |
| 1999-05-31 | $8.70M | -7.45% |
| 1998-05-31 | $9.40M | 2.17% |
| 1997-05-31 | $9.20M | -3.16% |
| 1996-05-31 | $9.50M | 3.26% |
| 1995-05-31 | $9.20M | 10.84% |
| 1994-05-31 | $8.30M | 3.75% |
| 1993-05-31 | $8.00M | - |
Biomerica generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Biomerica Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-02-29 | $1.02M | -35.10% |
| 2023-11-30 | $1.57M | -8.52% |
| 2023-08-31 | $1.71M | 54.57% |
| 2023-05-31 | $1.11M | -0.29% |
| 2023-02-28 | $1.11M | -25.00% |
| 2022-11-30 | $1.48M | -9.50% |
| 2022-08-31 | $1.64M | -69.12% |
| 2022-05-31 | $5.30M | -30.78% |
| 2022-02-28 | $7.66M | 64.85% |
| 2021-11-30 | $4.65M | 268.28% |
| 2021-08-31 | $1.26M | 19.71% |
| 2021-05-31 | $1.05M | -70.95% |
| 2021-02-28 | $3.63M | 164.38% |
| 2020-11-30 | $1.37M | 20.00% |
| 2020-08-31 | $1.14M | -58.03% |
| 2020-05-31 | $2.72M | 131.54% |
| 2020-02-29 | $1.18M | -26.28% |
| 2019-11-30 | $1.60M | 33.66% |
| 2019-08-31 | $1.19M | 2.45% |
| 2019-05-31 | $1.17M | -7.56% |
| 2019-02-28 | $1.26M | -15.97% |
| 2018-11-30 | $1.50M | 17.91% |
| 2018-08-31 | $1.27M | 12.60% |
| 2018-05-31 | $1.13M | -17.83% |
| 2018-02-28 | $1.38M | -14.75% |
| 2017-11-30 | $1.61M | 11.71% |
| 2017-08-31 | $1.44M | -0.34% |
| 2017-05-31 | $1.45M | -3.37% |
| 2017-02-28 | $1.50M | 4.73% |
| 2016-11-30 | $1.43M | 1.57% |
| 2016-08-31 | $1.41M | 6.33% |
| 2016-05-31 | $1.33M | -2.61% |
| 2016-02-29 | $1.36M | 16.87% |
| 2015-11-30 | $1.17M | -9.47% |
| 2015-08-31 | $1.29M | -13.91% |
| 2015-05-31 | $1.49M | 15.05% |
| 2015-02-28 | $1.30M | 14.63% |
| 2014-11-30 | $1.13M | 9.58% |
| 2014-08-31 | $1.03M | -38.39% |
| 2014-05-31 | $1.68M | 12.49% |
| 2014-02-28 | $1.49M | 59.68% |
| 2013-11-30 | $934.84K | -7.78% |
| 2013-08-31 | $1.01M | -31.06% |
| 2013-05-31 | $1.47M | 3.80% |
| 2013-02-28 | $1.42M | -24.79% |
| 2012-11-30 | $1.88M | 10.68% |
| 2012-08-31 | $1.70M | 10.36% |
| 2012-05-31 | $1.54M | 1.82% |
| 2012-02-29 | $1.51M | -6.31% |
| 2011-11-30 | $1.62M | 14.84% |
| 2011-08-31 | $1.41M | 15.86% |
| 2011-05-31 | $1.21M | -9.73% |
| 2011-02-28 | $1.35M | 15.94% |
| 2010-11-30 | $1.16M | -1.43% |
| 2010-08-31 | $1.18M | -15.71% |
| 2010-05-31 | $1.40M | -2.28% |
| 2010-02-28 | $1.43M | 29.98% |
| 2009-11-30 | $1.10M | -4.24% |
| 2009-08-31 | $1.15M | -7.84% |
| 2009-05-31 | $1.25M | -9.27% |
| 2009-02-28 | $1.37M | 22.58% |
| 2008-11-30 | $1.12M | -6.18% |
| 2008-08-31 | $1.19M | -9.39% |
| 2008-05-31 | $1.32M | 6.23% |
| 2008-02-29 | $1.24M | - |
Biomerica generated $1.02M in revenue during Q3 2024, up -35.10% compared to the previous quarter, and up 68.63% compared to the same period a year ago.
Biomerica Revenue Breakdown
Biomerica Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | May 21 | May 20 |
|---|---|---|
| PhysiciansOfficeMember | $2.80M | $2.19M |
| LabSuppliesMember | $3.00K | - |
| ClinicalLabMember | $3.08M | $2.92M |
| ContractManufacturingMember | $552.00K | $305.76K |
| OverthecounterMember | $766.00K | - |
| OTCMember | - | $1.27M |
Biomerica's latest annual revenue breakdown by segment (product or service), as of May 21: ClinicalLabMember (42.74%), PhysiciansOfficeMember (38.91%), OverthecounterMember (10.64%), ContractManufacturingMember (7.67%), and LabSuppliesMember (0.04%).
Quarterly Revenue by Product
| Product/Service | Feb 24 | Nov 23 | Feb 22 | Nov 21 | Aug 21 | May 21 | Feb 21 | Nov 20 | Aug 20 | May 20 | Feb 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Physician's Office | $3.00K | $1.00K | - | - | - | - | - | - | - | - | - |
| Clinical Lab | $404.00K | $992.00K | $723.00K | - | - | - | - | - | - | - | - |
| Contract Manufacturing | $281.00K | $131.00K | $151.00K | - | - | - | - | - | - | - | - |
| PhysiciansOfficeMember | - | - | $6.52M | $3.36M | $257.00K | $66.00K | $2.38M | $153.27K | $197.33K | $2.04M | - |
| ClinicalLabMember | - | - | $731.00K | $642.00K | $886.00K | $636.00K | $967.00K | $892.80K | $581.71K | $153.43K | - |
| ContractManufacturingMember | - | - | $167.00K | $112.00K | $40.00K | $191.00K | $130.00K | $51.34K | $179.86K | $41.76K | - |
| OverthecounterMember | - | - | $244.00K | $534.00K | $79.00K | - | - | - | - | - | - |
| LabSuppliesMember | - | - | - | - | - | - | $116.00 | $2.88K | - | - | - |
| OTCMember | - | - | - | - | - | - | $148.00K | $272.22K | $184.91K | $491.54K | - |
| Physicians Office | - | - | - | - | - | - | - | - | - | - | $32.00K |
| OTC | - | - | - | - | - | - | - | - | - | - | $271.00K |
Biomerica's latest quarterly revenue breakdown by segment (product or service), as of Feb 24: Clinical Lab (58.72%), Contract Manufacturing (40.84%), and Physician's Office (0.44%).
Biomerica Revenue Breakdown by Country
Annual Revenue by Country
| Country | May 21 | May 20 |
|---|---|---|
| ClinicalLabMember | $3.08M | $2.92M |
| PhysiciansOfficeMember | $2.80M | $2.19M |
| OverthecounterMember | $766.00K | - |
| LabSuppliesMember | $3.00K | - |
| ContractManufacturingMember | $552.00K | $305.76K |
| OTCMember | - | $1.27M |
Biomerica's latest annual revenue breakdown by geography, as of May 21: ClinicalLabMember (42.74%), PhysiciansOfficeMember (38.91%), OverthecounterMember (10.64%), ContractManufacturingMember (7.67%), and LabSuppliesMember (0.04%).
Quarterly Revenue by Country
| Country | Feb 23 | Feb 22 |
|---|---|---|
| Europe | $301.00K | - |
| South America | $5.00K | - |
| Asia | $345.00K | - |
| North America | $461.00K | - |
| PhysiciansOfficeMember | - | $6.52M |
| OverthecounterMember | - | $244.00K |
| ContractManufacturingMember | - | $167.00K |
| ClinicalLabMember | - | $731.00K |
Biomerica's latest quarterly revenue breakdown by geography, as of Feb 23: North America (41.46%), Asia (31.03%), Europe (27.07%), and South America (0.45%).
Biomerica Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| AZYO | Elutia | $49.19M | $6.13M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| TNON | Tenon Medical | $2.93M | $719.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| MOTS | Motus GI | $319.00K | $64.00K |
| AIMD | Ainos | $122.11K | - |
| NXL | Nexalin | $110.75K | $26.84K |
| MODD | Modular Medical | - | - |
| MOVE | Movano | - | - |
| BBLG | Bone Biologics | - | - |
| BMRA | Biomerica | - | $1.02M |
BMRA Revenue FAQ
What is Biomerica’s yearly revenue?
Biomerica's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $5.34M, representing a decrease of -71.71% compared to 2022. BMRA's yearly revenue for 2022 was $18.87M, representing an increase of 162.14% compared to 2021.
What is Biomerica’s quarterly revenue?
Biomerica's quarterly revenue for Q3 2024 was $1.02M, a -35.10% decrease from the previous quarter (Q2 2024), and a -8.50% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.57M, a -8.52% decrease from the previous quarter (Q1 2024), and a 5.74% increase year-over-year (Q2 2023). BMRA's quarterly revenue for Q1 2024 was $1.71M, a 54.57% increase from the previous quarter (Q4 2023), and a 4.61% increase year-over-year (Q1 2023).
What is Biomerica’s revenue growth rate?
Biomerica's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.
What are Biomerica’s revenue streams?
Biomerica's revenue streams in y 21 are PhysiciansOfficeMember, LabSuppliesMember, ClinicalLabMember, ContractManufacturingMember, and OverthecounterMember. PhysiciansOfficeMember generated $2.8M in revenue, accounting 38.91% of the company's total revenue, up 27.61% year-over-year. LabSuppliesMember generated $3K in revenue, accounting 0.04% of the company's total revenue ClinicalLabMember generated $3.08M in revenue, accounting 42.74% of the company's total revenue, up 5.29% year-over-year. ContractManufacturingMember generated $552K in revenue, accounting 7.67% of the company's total revenue, up 80.53% year-over-year. OverthecounterMember generated $766K in revenue, accounting 10.64% of the company's total revenue
What is Biomerica’s main source of revenue?
For the fiscal year ending May 21, the largest source of revenue of Biomerica was ClinicalLabMember. This segment made a revenue of $3.08M, representing 42.74% of the company's total revenue.